Ohshita T, Nikawa T, Towatari T, Katunuma N
Division of Enzyme Chemistry, University of Tokushima, Japan.
Eur J Biochem. 1992 Oct 1;209(1):223-31. doi: 10.1111/j.1432-1033.1992.tb17280.x.
Intraperitoneal administration of N-(L-trans-propylcarbamoyloxirane-2-carbonyl)-L-isoleucyl-L-prolin e (CA-074) to rats at a dose of 4 mg/100 g greatly inhibited cathepsin-B activity in both liver and kidney for at least 4 h. Its inhibitory effect was selective for cathepsin-B activity in the liver but not in the kidney. The effects of selective inhibition of cathepsin-B activity by CA-074 treatment, and general inhibition of cysteine proteinases by N-(L-3-trans-carboxyoxirane-2-carbonyl)-L-leucyl-3-methylbutylamid e (E-64-c) on the degradation of fluorescein isothiocyanate (FITC)-labeled asialofetuin in liver lysosomes, were examined in vivo. Undegraded or partially degraded FITC-labeled asialofetuin and its FITC-labeled degradation products were both found in the lysosomes and were easily separated by Sephadex G-25' column chromatography. The FITC-labeled degradation products were mainly lysine with an FITC-labeled epsilon-amino group. Accumulation of undegraded or partially degraded FITC-labeled asialofetuin in the lysosomes was marked after E-64-c treatment, but slight after CA-074 treatment. Under the marked inhibition of general lysosomal cysteine-proteinase activity by E-64-c or marked selective inhibition of cathepsin-B activity by CA-074 in vitro, degradation of FITC-labeled asialofetuin by disrupted lysosomes was analyzed on the basis of measurement of FITC-labeled degradation products by Sephadex G-25 column chromatography. It was suppressed markedly but incompletely by E-64-c as well as by CA-074, but more weakly than by E-64-c. These results shows that E-64-sensitive cysteine proteinases are important in lysosomal protein degradation, but cathepsin B has only a role in part and that an E-64-resistant proteinase(s) may also be important.
以4mg/100g的剂量向大鼠腹膜内注射N-(L-反式-丙基氨甲酰氧基环氧乙烷-2-羰基)-L-异亮氨酰-L-脯氨酸(CA-074),可在至少4小时内显著抑制肝脏和肾脏中的组织蛋白酶B活性。其抑制作用对肝脏中的组织蛋白酶B活性具有选择性,而对肾脏中的则无选择性。在体内研究了CA-074处理对组织蛋白酶B活性的选择性抑制作用,以及N-(L-3-反式-羧基环氧乙烷-2-羰基)-L-亮氨酰-3-甲基丁酰胺(E-64-c)对半胱氨酸蛋白酶的全面抑制作用对肝脏溶酶体中异硫氰酸荧光素(FITC)标记的去唾液酸胎球蛋白降解的影响。在溶酶体中发现了未降解或部分降解的FITC标记的去唾液酸胎球蛋白及其FITC标记的降解产物,并且通过葡聚糖凝胶G-25'柱色谱法很容易将它们分离。FITC标记的降解产物主要是带有FITC标记的ε-氨基的赖氨酸。E-64-c处理后,溶酶体中未降解或部分降解的FITC标记的去唾液酸胎球蛋白积累明显,但CA-074处理后则轻微。在体外E-64-c对溶酶体半胱氨酸蛋白酶活性的显著抑制或CA-074对组织蛋白酶B活性的显著选择性抑制下,基于通过葡聚糖凝胶G-25柱色谱法测量FITC标记的降解产物,分析了破碎溶酶体对FITC标记的去唾液酸胎球蛋白的降解作用。E-64-c和CA-074均能显著但不完全地抑制其降解,不过CA-074的抑制作用比E-64-c弱。这些结果表明,E-64敏感的半胱氨酸蛋白酶在溶酶体蛋白降解中很重要,但组织蛋白酶B仅起部分作用,并且一种或多种E-64抗性蛋白酶可能也很重要。